Stay updated on Pembrolizumab Combo in Metastatic Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Metastatic Lung Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new publication citation was added to the Publications section (Gadgeel et al., 2024), updating the study’s references. The page revision is noted as v3.5.4.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe page revision label was updated from **v3.5.2** to **v3.5.3**, indicating a minor technical version update without altering the displayed study information.SummaryDifference0.0%

- Check44 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.0%

- Check73 days agoChange DetectedRevision: v3.5.0 was added. Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check80 days agoChange DetectedWebsite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check108 days agoChange DetectedA new Revision: v3.4.2 is displayed, and the previous government funding lapse notice has been removed.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab Combo in Metastatic Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic Lung Cancer Clinical Trial page.